Capital raised by Nok Therapeutics
6 Form D filings · first filed Jun 2024 · Cranberry Twp., PA
President and Chief Executive Officer
Signatory on Nok Therapeutics's Form D filings · $1.4M raised across 6
Robert Lewis is on file as President and Chief Executive Officer at Nok Therapeutics in Cranberry Twp., PA. Nok Therapeutics has 6 Form D filings on record, $1.4M raised in total. Robert Lewis appears as a signatory on the company's filings.
A cell therapy platform that harvests a patient's own natural killer cells, expands them ex vivo without genetic engineering, and re-infuses them to restore immune defense against cancer, notably as consolidation after autologous stem cell transplant in multiple myeloma.
